236 related articles for article (PubMed ID: 16438873)
1. [Imaging evaluation of efficacy of radiofrequency ablation treatment for hepatic cancer].
Zhang ZJ; Wu MC; Liu Q; Chen D
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):616-9. PubMed ID: 16438873
[TBL] [Abstract][Full Text] [Related]
2. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
[TBL] [Abstract][Full Text] [Related]
3. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
[TBL] [Abstract][Full Text] [Related]
5. [Percutaneous radiofrequency ablation with artificial hydrothorax for liver cancer in the hepatic dome].
Han Y; Yu L; Hao YZ; Yang M; Liu S; Deng YB; He LF; Cai JQ; Chen MH
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):846-9. PubMed ID: 23291135
[TBL] [Abstract][Full Text] [Related]
6. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
[TBL] [Abstract][Full Text] [Related]
7. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography.
Nakai M; Sato M; Sahara S; Takasaka I; Kawai N; Minamiguchi H; Tanihata H; Kimura M; Takeuchi N
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):62-9. PubMed ID: 18987911
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
11. [Results of enhanced ultrasonography in assessing hepatoma treated with radiofrequency ablation].
Yan K; Chen MH; Dai Y; Shen L; Jiang XL
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):41-4. PubMed ID: 15771798
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT.
Fujioka C; Horiguchi J; Ishifuro M; Kakizawa H; Kiguchi M; Matsuura N; Hieda M; Tachikake T; Alam F; Furukawa T; Ito K
Acad Radiol; 2006 Aug; 13(8):986-94. PubMed ID: 16843851
[TBL] [Abstract][Full Text] [Related]
13. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
Minami Y; Kitai S; Kudo M
Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
[TBL] [Abstract][Full Text] [Related]
14. Local curative effect of MRI-guided radiofrequency ablation on small hepatocellular carcinoma.
Lin ZY; Song QQ; Chen J; Wan RJ; Zheng H; Chen ZW; Chen YP; Hua WC
Tumour Biol; 2015 Mar; 36(3):2105-10. PubMed ID: 25501700
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
16. Unenhanced magnetic resonance imaging immediately after radiofrequency ablation of liver malignancy: preliminary results.
D'Onofrio M; Cardobi N; Ruzzenente A; Conci S; Ciaravino V; Guglielmi A; Mucelli RP
Abdom Radiol (NY); 2018 Jun; 43(6):1379-1385. PubMed ID: 28861631
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma.
Yuan C; Yuan Z; Cui X; Gao W; Zhao P; He N; Cui S; Wang Y; Zhang Y; Li W; Zheng J
J Cancer Res Ther; 2019; 15(4):784-792. PubMed ID: 31436232
[TBL] [Abstract][Full Text] [Related]
18. [Ultrasound guided ablation therapy of hepatic colorectal metastases: initial experience of real time virtual sonography navigation system].
Yuan CH; Xiu DR; Ge HY; Tan S; Wang HY; Zhang L; Zhang TL
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):956-9. PubMed ID: 24343081
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Hori M; Kudo M; Murakami T
Dig Dis; 2013; 31(5-6):485-9. PubMed ID: 24281025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]